EA201691793A1 - Способ получения состава на основе вилдаглиптина в атмосфере инертного газа - Google Patents
Способ получения состава на основе вилдаглиптина в атмосфере инертного газаInfo
- Publication number
- EA201691793A1 EA201691793A1 EA201691793A EA201691793A EA201691793A1 EA 201691793 A1 EA201691793 A1 EA 201691793A1 EA 201691793 A EA201691793 A EA 201691793A EA 201691793 A EA201691793 A EA 201691793A EA 201691793 A1 EA201691793 A1 EA 201691793A1
- Authority
- EA
- Eurasian Patent Office
- Prior art keywords
- inert gas
- gas atmosphere
- vildagliptina
- obtaining
- composition based
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2009—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Inorganic Chemistry (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Abstract
Настоящее изобретение относится к способу получения фармацевтической композиции на основе вилдаглиптина в атмосфере инертного газа, не содержащей кислорода. Настоящее изобретение, в частности, относится к фармацевтической композиции на основе вилдаглиптина, полученной посредством данного способа, которая является физиологически и химически стабильной при воздействии кислорода.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
TR2014/02685A TR201402685A1 (tr) | 2014-03-06 | 2014-03-06 | Vildagliptinin farmasotik formulasyonları. |
TR201412836 | 2014-11-03 | ||
PCT/EP2015/054666 WO2015132359A1 (en) | 2014-03-06 | 2015-03-05 | Vildagliptin formulation process under inert gas atmosphere |
Publications (1)
Publication Number | Publication Date |
---|---|
EA201691793A1 true EA201691793A1 (ru) | 2016-12-30 |
Family
ID=52726949
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EA201691793A EA201691793A1 (ru) | 2014-03-06 | 2015-03-05 | Способ получения состава на основе вилдаглиптина в атмосфере инертного газа |
Country Status (4)
Country | Link |
---|---|
US (1) | US20170014380A1 (ru) |
EP (1) | EP2915528A1 (ru) |
EA (1) | EA201691793A1 (ru) |
WO (1) | WO2015132359A1 (ru) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TR202010700A2 (tr) * | 2020-07-06 | 2022-01-21 | Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi | Vi̇ldagli̇pti̇n ve en az bi̇r farmasöti̇k olarak kabul edi̇lebi̇li̇r eksi̇pi̇yan i̇çeren bi̇r formülasyon |
CN112957355A (zh) * | 2021-04-07 | 2021-06-15 | 烟台万润药业有限公司 | 一种维格列汀片剂及其制备方法 |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CO5150173A1 (es) | 1998-12-10 | 2002-04-29 | Novartis Ag | Compuestos n-(glicilo sustituido)-2-cianopirrolidinas inhibidores de peptidasa de dipeptidilo-iv (dpp-iv) los cuales son efectivos en el tratamiento de condiciones mediadas por la inhibicion de dpp-iv |
JP4939217B2 (ja) * | 2003-08-06 | 2012-05-23 | グリューネンタ−ル・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツング | 乱用防止剤形 |
PL3738585T3 (pl) | 2004-01-20 | 2023-04-17 | Novartis Ag | Preparat i sposób jego bezpośredniego prasowania |
GT200600008A (es) | 2005-01-18 | 2006-08-09 | Formulacion de compresion directa y proceso | |
MY152185A (en) | 2005-06-10 | 2014-08-29 | Novartis Ag | Modified release 1-[(3-hydroxy-adamant-1-ylamino)-acetyl]-pyrrolidine-2(s)-carbonitrile formulation |
EP2578208B1 (en) * | 2011-10-06 | 2014-05-21 | Sanovel Ilac Sanayi ve Ticaret A.S. | DPP-IV inhibitor solid dosage formulations |
US10996236B2 (en) * | 2014-07-22 | 2021-05-04 | Fisher Controls International Llc | Control device position feedback with accelerometer |
-
2015
- 2015-03-05 US US15/123,822 patent/US20170014380A1/en not_active Abandoned
- 2015-03-05 EA EA201691793A patent/EA201691793A1/ru unknown
- 2015-03-05 WO PCT/EP2015/054666 patent/WO2015132359A1/en active Application Filing
- 2015-03-05 EP EP15157825.9A patent/EP2915528A1/en not_active Withdrawn
Also Published As
Publication number | Publication date |
---|---|
EP2915528A1 (en) | 2015-09-09 |
US20170014380A1 (en) | 2017-01-19 |
WO2015132359A1 (en) | 2015-09-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GEP20207182B (en) | Cyclic di-nucleotide compounds as sting agonists | |
EA201790630A1 (ru) | Способы получения рибозидов | |
EA202092987A2 (ru) | Липид, содержащий докозапентаеновую кислоту | |
EP4282983A3 (en) | Compositions and methods for polynucleotide sequencing | |
MX2017008136A (es) | Sal de l-tartrato de pridopidina. | |
CY1124587T1 (el) | Μεθοδος για την παρασκευη toy brivaracetam | |
BR112017012210A2 (pt) | solução conservante de célula, uso da mesma e método de produção de solução conservante de célula | |
EA202091397A1 (ru) | Бензохинолоновые ингибиторы vmat2 | |
TW201612319A (en) | Microorganism producing O-phosphoserine and a method for producing O-phosphoserine or L-cysteine using the same | |
EA201691649A1 (ru) | Способ получения противогрибковых соединений | |
CY1120759T1 (el) | Παρασκευη διγλυκοζιτη (s,s)-σεκοϊσολαρικιρεσινολης και διγλυκοζιτη (r,r)-σεκοϊσολαρικιρεσινολης | |
EA201591712A1 (ru) | Антибиотические композиции на основе цефтолозана | |
EA201691648A1 (ru) | Способ получения противогрибковых соединений | |
PH12016502002B1 (en) | Novel bacteriophage and composition comprising same | |
MX2018003678A (es) | Metodos moleculares de aseguramiento de la calidad para su uso en la secuenciacion. | |
MX2017005578A (es) | Métodos de administración de composiciones de amantadina. | |
EA201690793A1 (ru) | Способ получения лиофилизированной фармацевтической композиции, содержащей митомицин c | |
TW201613953A (en) | Process for the preparation of cyclic depsipeptides | |
EA201890177A1 (ru) | Мультиспецифические связывающие белки | |
CY1124569T1 (el) | Φαρμακοτεχνικη μορφη που περιεχει γλυκοπυρρολικο, μεθοδος και συσκευη | |
MX2023009432A (es) | Metodo para crear un compuesto a base de mercurio, compuesto a base de mercurio, metodos de uso del compuesto a base de mercurio y usos del compuesto a base de mercurio. | |
EA201992168A1 (ru) | Аналоги деутетрабеназина, их получение и применение | |
EA201691793A1 (ru) | Способ получения состава на основе вилдаглиптина в атмосфере инертного газа | |
EA201890818A1 (ru) | Режим комбинированной терапии для лечения hcv | |
BR112018003714A8 (pt) | Composições de ácido de peso aumentado que compreendem aminoácidos |